Phellinus baumii ethyl acetate extract inhibits lipopolysaccharide-induced iNOS, COX-2, and proinflammatory cytokine expression in RAW264.7 cells

Journal of Natural Medicines

Volumn 66, Issue 1, 2012, Pages 49-54

  Yayeh, Taddesse ^a   Oh, Won Jun ^a   Park, Seung Choon ^a   Kim, Tae Hwan ^a   Cho, Jae Youl ^b   Park, Hwa Jin ^c   Lee, In Kyoung ^d   Kim, Sang Keun ^e   Hong, Seung Bok ^f   Yun, Bong Sik ^d   Rhee, Man Hee ^a  

^a Kyungpook National University   (South Korea)

^b Sungkyunkwan University   (South Korea)

^c Inje University   (South Korea)

^d Chonbuk National University   (South Korea)

^e Chungnam National University   (South Korea)

^f Juseong College   (South Korea)

Author keywords

Inflammation; Inflammatory mediator; Macrophage; P. baumii; Proinflammatory cytokine

Indexed keywords

ACETIC ACID ETHYL ESTER; CYCLOOXYGENASE 2; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; NITRIC OXIDE; PHELLINUS BAUMII EXTRACT; PLANT EXTRACT; PROSTAGLANDIN E2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL STIMULATION; CELL STRAIN RAW264.7; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG CYTOTOXICITY; DRUG ISOLATION; DRUG TARGETING; ENZYME IMMUNOASSAY; GENE EXPRESSION; GENE EXPRESSION PROFILING; INFLAMMATION; MACROPHAGE; MEDIATOR RELEASE; MOUSE; NONHUMAN; PHELLINUS; PHELLINUS BAUMII; PROSTAGLANDIN SYNTHESIS INHIBITION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ACETATES; AGARICALES; ANIMALS; ANTI-INFLAMMATORY AGENTS; BLOTTING, WESTERN; CELL LINE; CYCLOOXYGENASE 2; CYTOKINES; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; IMMUNOENZYME TECHNIQUES; INFLAMMATION MEDIATORS; INTERLEUKIN-1BETA; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MACROPHAGES; MEDICINE, TRADITIONAL; MICE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SOLVENTS;

EID: 84856224961     PISSN: 13403443     EISSN: 18610293     Source Type: Journal    
DOI: 10.1007/s11418-011-0552-8     Document Type: Article

References (38)

1. Fujihara M, Muroi M, Tanamoto K, Suzuki T, Azuma H, Ikeda H (2003) Molecular mechanisms of macrophage activation and deactivation by lipopolysaccharide: roles of the receptor complex. Pharmacol Ther 100:171-194 (Pubitemid 37377912)
2. Kuroda E, Yamashita U (2003) Mechanisms of enhanced macrophage- mediated prostaglandin E2 production and its suppressive role in Th1 activation in Th2-dominant BALB/c mice. J Immunol 170:757-764 (Pubitemid 36070526)
3. Laskin DL, Sunil VR, Gardner CR, Laskin JD (2011) Macrophages and tissue injury: agents of defense or destruction? Annu Rev Pharmacol Toxicol 51:267-288
4. Alderton WK, Cooper CE, Knowles RG (2001) Nitric oxide synthases: structure, function and inhibition. Biochem J 357: 593-615 (Pubitemid 32735142)
5. Aktan F (2004) iNOS-mediated nitric oxide production and its regulation. Life Sci 75:639-653 (Pubitemid 38686696)
6. Davis KL, Martin E, Turko IV, Murad F (2001) Novel effects of nitric oxide. Annu Rev Pharmacol Toxicol 41:203-236 (Pubitemid 32385888)
7. Marcinkiewicz J, Grabowska A, Chain B (1995) Nitric oxide upregulates the release of inflammatory mediators by mouse macrophages. Eur J Immunol 25:947-951
8. Gross SS, Wolin MS (1995) Nitric oxide: pathophysiological mechanisms. Annu Rev Physiol 57:737-769
9. Marnett LJ (2009) The COXIB experience: a look in the rearview mirror. Annu Rev Pharmacol Toxicol 49:265-290
10. Turini ME, DuBois RN (2002) Cyclooxygenase-2: a therapeutic target. Annu Rev Med 53:35-57 (Pubitemid 34177870)
11. Cha YI, DuBois RN (2007) NSAIDs and cancer prevention: targets downstream of COX-2. Annu Rev Med 58:239-252 (Pubitemid 46706512)
12. Dinarello CA (2000) Proinflammatory cytokines. Chest 118: 503-508 (Pubitemid 30637822)
13. Dinarello CA (2009) Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol 27:519-550
14. Hercus TR, Thomas D, Guthridge MA, Ekert PG, King-Scott J, Parker MW, Lopez AF (2009) The granulocyte-macrophage colony-stimulating factor receptor: linking its structure to cell signaling and its role in disease. Blood 114:1289-1298
15. Germano G, Allavena P, Mantovani A (2008) Cytokines as a key component of cancer-related inflammation. Cytokine 43:374-379
16. Ahmed S, Anuntiyo J, Malemud CJ, Haqqi TM (2005) Biological basis for the use of botanicals in osteoarthritis and rheumatoid arthritis: a review. Evid Based Complement Alternat Med 2:301-308 (Pubitemid 41253342)
17. Cheung PCK (2010) The nutritional and health benefits of mushrooms. Nutr Bull 35:292-299
18. Singh RS, Bhari R, Kaur HP (2010) Mushroom lectins: current status and future perspectives. Crit Rev Biotechnol 30:99-126
19. Wasser SP (2002) Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides. Appl Microbiol Biotechnol 60:258-274
20. Ge Q, Zhang A-Q, Sun P-L (2010) Isolation, purification and structural characterization of a novel water soluble glucan from the fruiting bodies of Phellinus baumii pilat. J Food Biochem 34:1205-1215
21. Shon M-Y, Kim T-H, Sung N-J (2003) Antioxidants and free radical scavenging activity of Phellinus baumii (Phellinus of Hymenochaetaceae) extracts. Food Chem 82:593-597 (Pubitemid 36842830)
22. Noh J-R, Lee I-K, Ly S-Y, Yang K-J, Gang G-T, Kim Y-H, Hwang J-H, Yun B-S, Lee C-H (2011) A Phellinus baumii extract reduces obesity in high-fat diet-fed mice and absorption of triglyceride in lipid-loaded mice. J Med Food 14:209-218
23. Jang BS, Kim JC, Bae JS, Rhee MH, Jang KH, Song JC, Kwon OD, Park SC (2004) Extracts of Phellinus gilvus and Phellinus baumii inhibit pulmonary inflammation induced by lipopolysaccharide in rats. Biotechnol Lett 26:31-33
24. Chang Z, Oh B, Rhee M, Kim J, Lee S, Park S (2007) Polysaccharides isolated from Phellinus baumii stimulate murine splenocyte proliferation and inhibit the lipopolysaccharideinduced nitric oxide production in RAW264.7 murine macrophages. World J Microbiol Biotechnol 23:723-727 (Pubitemid 46714392)
25. Kamruzzaman SM, Endale M, Oh WJ, Park SC, Kim TH, Lee IK, Cho JY, Park HJ, Kim SK, Yun BS, Rhee MH (2011) Antiplatelet activity of Phellinus baummii methanol extract is mediated by cyclic AMP elevation and inhibition of collagen-activated integrin- alpha(IIb) beta(3) and MAP kinase. Phytother Res. doi: 10.1002/ptr.3450
26. Jose N, Ajith TA, Janardhanan KK (2004) Methanol extract of the oyster mushroom, Pleurotus florida, inhibits inflammation and platelet aggregation. Phytother Res 18:43-46 (Pubitemid 38173502)
27. Smith JE, Rowan NJ, Sullivan R (2002) Medicinal mushrooms: a rapidly developing area of biotechnology for cancer therapy and other bioactivities. Biotechnol Lett 24:1839-1845 (Pubitemid 35399816)
28. Lee IK, Yun BS (2011) Styrylpyrone-class compounds from medicinal fungi Phellinus and Inonotus spp., and their medicinal importance. J Antibiot 64:349-359. doi:10.1038/ja.2011.2
29. Chun KS, Surh YJ (2004) Signal transduction pathways regulating cyclooxygenase-2 expression: potential molecular targets for chemoprevention. Biochem Pharmacol 68:1089-1100
30. Mantovani A, Allavena P, Sica A, Balkwill F (2008) Cancerrelated inflammation. Nature 454:436-444
31. Milella M, Metro G, Gelibter A, Pino SM, Cognetti F, Fabi A (2008) COX-2 targeting in cancer: a new beginning? Ann Oncol 19:1209-1210 (Pubitemid 351796353)
32. Mukherjee D, Nissen SE, Topol EJ (2001) Risk of cardiovascular events associated with selective COX-2 inhibitors. Jama 286:954-959 (Pubitemid 33010342)
33. TG FrancoL (2009) Cross-talk between inducible nitric oxide synthase and cyclooxygenase in Helicobacter-pylori-induced gastritis. Med Princ Pract 18:477-481
34. Uno K, Iuchi Y, Fujii J, Sugata H, Iijima K, Kato K, Shimosegawa T, Yoshimura T (2004) In vivo study on cross talk between inducible nitric-oxide synthase and cyclooxygenase in rat gastric mucosa: effect of cyclooxygenase activity on nitric oxide production. J Pharmacol Exp Ther 309:995-1002 (Pubitemid 38669685)
35. Perez-Sala D, Lamas S (2001) Regulation of cyclooxygenase-2 expression by nitric oxide in cells. Antioxid Redox Signal 3:231-248 (Pubitemid 32473339)
36. Charles A, Dinarello MD (2009) Interleukin-1b and the autoinflammatory diseases. N Engl J Med 360:2467-2470
37. Fonseca JE, Santos MJ, Canhao H, Choy E (2009) Interleukin-6 as a key player in systemic inflammation and joint destruction. Autoimmun Rev 8:538-542
38. Kim SJ, Choi Y, Choi YH, Park T (2011) Obesity activates toll-like receptor-mediated proinflammatory signaling cascades in the adipose tissue of mice. J Nutr Biochem. doi:10.1016/j. jnutbio.2010.10.012